Cloudpharm Private Company

Cloudpharm Private Company is an SME in Aigaleo, Greece that has taken part in 2 EU-funded projects since 2022, receiving €589k in EU funding.

EU funding received€589k
EU projects2
As coordinator0
Running now1
First EU project2022
Latest project2025
CountryGreece
EU registration (PIC)917093873
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Cloudpharm Private Company's own share of each project, not the project's full budget.

  • Horizon Europe€589k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • FRUITPRINTPartner

    Design of novel post-harvest technologies with low carbon footprint based on the discovery of active biomolecules

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €55ktheir share
  • ENVIROMEDPartner

    Next generation toolbox for greener pharmaceuticals design & manufacturing towards reduced environmental impact

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €533ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • biosensors
  • fruit growing
  • pharmaceutical drugs
  • physiology
  • renewable energy
  • vegetable growing

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime